Universal Health Organisation (UHO) Weekly Newsletter – 12 December 2025

Highlights:

• Cardiologists warn of “Covid’s Silent Aftermath,” remain “Silent Over Covid Vaccines.”
• A flawed study from France goes one step further, not only covering up vaccine harms but also finding all-cause mortality lower in those who received Covid vaccines!
• Carrying the baton for the next lap, “long-covid-bogey” gets huge funding in Germany
• Ray of hope: the FDA is investigating the ill effects of COVID-19 jabs on adults
• Hindi news media Dainik Bhaskar publishes the potential ill-effects of the COVID-19 jabs

Website: https://uho.org.in

Download: https://uho.org.in/nl/2025-12-12-newsletter.pdf (copy and paste the link)

On December 12th, 2025, Professor Amitav Banerjee, Chairperson of the UHO, presented a newsletter discussing recent developments regarding COVID-19 vaccinations, potential side effects, and ongoing research efforts. It is critical for understanding the evolving perceptions and scientific inquiries surrounding the vaccine and its implications on public health.

1. Emerging Concerns about Vaccine Side Effects:
   • Reports have surfaced indicating potential side effects related to COVID-19 vaccines, particularly an increase in heart disease and sudden cardiac events.
   • Notably, mainstream medical commentary largely attributes these issues to long COVID, neglecting to investigate possible vaccine connections — a point raised by multiple cardiologists.
2. Government and Institutional Actions:
   • A recent inquiry by the UK government suggested that more stringent measures could have been imposed, implying a protective stance regarding previous vaccination policies.
   • In Germany, substantial funding has been allocated to research long COVID, while similar investigations into long-term vaccine effects appear underrepresented.
3. Conflicting Study Results:
   • A large French study published in JAMA found that vaccinated individuals had lower all-cause mortality compared to unvaccinated ones. However, criticisms arose over the study’s methodology, particularly its failure to adequately control for socioeconomic factors that could skew findings.
   • The assumption that vaccine recipients generally had better overall health is under scrutiny, given disparities in healthcare access among demographic groups.
4. Investigative Leverage and Public Inquiries:
   • Investigations led by the U.S. FDA into vaccine side effects are deemed a positive development and a step toward transparency.
   • Indian cardiologist Dr. Deepak Natarajan’s previous work has identified vaccine-related myocarditis through biopsy studies, yet there seems to be a lack of broader acknowledgment among colleagues in the medical field.
5. Media Coverage and Public Awareness:
   • An investigative report from Dainik Bhaskar revealed that the Indian government has privately acknowledged the occurrence of vaccine-related side effects, including paralysis and strokes, although publicly these associations remain contested.
   • The report noted a fourfold increase in neurological disorders related to vaccinations from 2017 to 2025, raising alarms about the need for further investigation.

The newsletter underscores a critical need for enhanced scrutiny into the safety and efficacy of COVID-19 vaccines. It highlights gaps in public health research, particularly in understanding vaccine side effects versus those attributed solely to the virus. The balance between promoting vaccination and acknowledging its potential risks is consistently urged, alongside a call for independent research not hindered by political or institutional pressures. Overall, ongoing developments and inquiries signify a complex and evolving discourse regarding COVID-19 vaccinations that warrants close attention from health officials, policymakers, and the public at large.

Also Read: